Raymond James & Associates’s AvePoint AVPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,300
Closed -$53K 3954
2022
Q2
$53K Sell
12,300
-6,946
-36% -$35.3K ﹤0.01% 3782
2022
Q1
$101K Sell
19,246
-9,662
-33% -$55.3K ﹤0.01% 3820
2021
Q4
$182K Sell
28,908
-16,782
-37% -$130K ﹤0.01% 3727
2021
Q3
$388K Sell
45,690
-4,527
-9% -$45K ﹤0.01% 3241
2021
Q2
$615K Buy
+50,217
New +$548K ﹤0.01% 2938

Other funds holding AVPT

Raymond James & Associates's AVPT Position: Q3 2022 in Review

Raymond James & Associates sold out of AvePoint (AVPT) in Q3 2022, closing a stake of 12,300 shares — an estimated $53K sold.

Raymond James & Associates first reported a position in AVPT in Q2 2021 and held it in 5 quarters. The position peaked at $615K in Q2 2021. 95 funds tracked by Wall St. Rank hold AVPT as of Q3 2022.

  • Raymond James & Associates reported no remaining AvePoint position as of Q3 2022 after selling out during the quarter.
  • Raymond James & Associates sold 12,300 AvePoint shares in Q3 2022, an estimated $53K.
  • Raymond James & Associates first reported a position in AvePoint in Q2 2021 and held it in 5 quarters.
  • Raymond James & Associates's AvePoint position peaked at $615K in Q2 2021.
  • 95 funds tracked by Wall St. Rank held AvePoint as of Q3 2022.

Based on Raymond James & Associates's 13F filing for Q3 2022, filed 25 Oct 2022.